Sign in

CIK 0001651625 · Accelerated filer

AC Immune SA

Sign in to watch
Ticker
ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
41 21 345 91 21
Business address
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, Switzerland, 00000
  1. 3/A Insider 3/A
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 16,568 shares (grant or award)
  4. 4 Grant or award Director acquired 16,568 shares (grant or award)
  5. 4 Grant or award Interim CEO acquired 33,136 shares (grant or award)
  6. 4 Grant or award Director acquired 17,751 shares (grant or award)
  7. 4 Grant or award Director acquired 16,568 shares (grant or award)
  8. 4 Planned sale Chief Executive Officer sold 10,000 shares at $2.79 ($27,935)
  9. 4/A Planned sale Chief Executive Officer sold 10,000 shares at $3.14 ($31,425)
  10. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.14 ($31,425)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 18 filings